Is this you? Create Your Porfile
Avatar

Janet Johnson

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Janet Johnson is active.

Explore More

Publication

Featured researches published by Janet Johnson.

Neurology | 2016

Adjunctive Extended-Release Molindone (SPN-810) to Manage Impulsive Aggression in Children with Attention Deficit/Hyperactivity Disorder (ADHD) Receiving Optimized Stimulant Monotherapy and Behavioral Therapy (P6.214)

Scott Brittain; Jennifer Dugan Stocks; Janet Johnson; Tesfaye Liranso; Robert L. Findling

Journal of the American Academy of Child and Adolescent Psychiatry | 2016

5.40 LONG-TERM EFFICACY AND SAFETY OF EXTENDED-RELEASE MOLINDONE (SPN-810) TO MANAGE IMPULSIVE AGGRESSION IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Toyin Adewole; Scott Brittain; Janet Johnson; Tesfaye Liranso; Robert L. Findling

Neurology | 2015

Population Pharmacokinetic Modeling of Extended-Release Topiramate (SPN-538, Trokendi XR®) in Children with Epilepsy (P1.245)

Scott Brittain; Janet Johnson

Neurology | 2014

Pharmacokinetic Rationale for mg-to-mg Overnight Switch from b.i.d. Immediate Release Topiramate (TPM-IR) to Extended-Release Once-Daily SPN-538 (Trokendi XR™) (P3.244)

Jennifer Dugan Stocks; Janet Johnson; Scott Brittain; Paolo Baroldi

Neurology | 2014

Oxcarbazepine Pharmacokinetics of Extended-Release Once-Daily SPN-804 (Oxtellar XR™) in the Elderly (P3.248)

Welton O'Neal; Scott Brittain; Janet Johnson

Neurology | 2014

Steady-State Bioequivalence of Extended-Release Once-Daily SPN-538 (Trokendi XR™) to Immediate-Release Topiramate (TPM-IR, Topamax®) (P3.245)

Janet Johnson; Scott Brittain; Jennifer Dugan Stocks; Paolo Baroldi

Neurology | 2014

Cognitive Effects of Extended-Release Once-Daily SPN-538 (Trokendi XR™) vs b.i.d. Immediate-Release Topiramate (TPM-IR, Topamax®) in Healthy Volunteers (S43.002)

Janet Johnson; Scott Brittain; Stefan Schwabe

Neurology | 2014

Pharmacokinetic-Pharmacodynamic Analysis of Extended-Release Once-Daily Oxcarbazepine Formulation SPN-804 (Oxtellar XR™) in Adults with Epilepsy (P3.247)

Scott Brittain; Janet Johnson; Paolo Baroldi

Neurology | 2014

Topiramate Pharmacokinetics of Extended-Release Once-Daily SPN-538 (Trokendi XR™) in the Elderly (P3.246)

Welton O'Neal; Scott Brittain; Jennifer Dugan Stocks; Janet Johnson; Paolo Baroldi

Neurology | 2013

Long-Term, Open-Label Safety and Tolerability Study of Once-Daily Extended-Release Oxcarbazepine (SPN-804) as Adjunctive Therapy in Patients with Refractory Partial Seizures (P04.211)

Janet Johnson; Scott Brittain; Dawn Louro

Explore More

Collaboration

Dive into the Janet Johnson's collaboration.

Top Co-Authors
Avatar

Robert L. Findling

Johns Hopkins University

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge